Product peptide-diabetes-peptides

Home > products > peptide> diabetes-peptides

Catalog	name	Description	price
R-R-0485	Biotin-Glucagon-Like Peptide 1 (7 - 36), amide, human	Biotin-Glucagon-Like Peptide 1 (7-36) amide, human is a biologically active peptide. Biotin-Glucagon-Like Peptide 1 (7-36) amide, human can be used for the research of various biochemical studies.	price>
R-R-0486	Glucagon-Like Peptide-1 (7-17)-Cys	Glucagon-Like Peptide-1 (GLP-1) (7-17)-Cys/GLP-1 (7 - 17)-Cys is a modified form of the peptide hormone GLP-1. This modification involves the addition of a cysteine (Cys) residue to the seventh position of the peptide sequence.	price>
R-R-0672	GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat)	GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat)/CAS.1802086-70-9 is a biotinylated GLP-1 fragment, corresponding to the 7-36 sequence of GLP-1.	price>
R-R-0872	[Des-His1,Glu9]-Glucagon amide TFA	[Des-His1,Glu9]-Glucagon amide TFA is a potent and peptide antagonist of the glucagon receptor, with a pA2 of 7.2. [Des-His1,Glu9]-Glucagon amide TFA is potentially useful in the study of the pathogenesis of diabetes.	price>
R-R-0894	GLP-1 receptor agonist 7	GLP-1 receptor agonist 7/CAS No.2736447-04-2 is a potent agonist of glucagon-like peptide-1 (GLP-1). GLP-1 receptor agonist 7 has the potential for the research of GLP-1-associated diseases, disorders, and conditions including diabetes mellitus .	price>
R-R-0942	[D-Ala2]-GIP (human)	[D-Ala2]-GIP (human)/CAS.444073-04-5 is a GIP receptor agonist. [D-Ala2]-GIP (human) improves glucose tolerance. [D-Ala2]-GIP (human) shows neuroprotective activity in MPTP-induced Parkinson disease model. [D-Ala2]-GIP (human) also improves cognitive function and hippocampal synaptic plasticity in obese diabetic rats.	price>
R-M-179	Preptin (human) trifluoroacetate salt,CAS :315197-69-4	Preptin is a 34-amino acid peptide hormone, corresponding to Asp⁶⁹-Leu¹⁰² of the proinsulin-like growth factor II E-peptide. It is co-secreted with insulin and amylin from the pancreatic β-cells and is a physiological amplifier of glucose-mediated insulin secretion. It is also anabolic to bone tissue and may contribute to the preservation of bone mass observed in hyperinsulinemic states such as obesity.	price>
R-M-180	Preptin (rat) trifluoroacetate salt,CAS : 315197-73-0	Preptin is a 34-amino acid peptide hormone, which is co-secreted with insulin from the pancreatic β-cells in response to glucose stimulation. It is osteogenic in vitro and in vivo and may act in concert with the other β-cell hormones insulin and amylin to stimulate bone formation in hyperinsulinemic states such as obesity.	price>
R-M-181	Adropin (34-76) (human, mouse, rat) trifluoroacetate salt, CAS :1802086-30-1	Adropin is a secreted factor involved in energy homeostasis and lipid metabolism. It is encoded by the energy homeostasis associated gene (Enho) and is expressed in liver and brain. In diet-induced obesity (DIO) mice Adropin (34-76) attenuated hepatosteatosis and insulin reistance independently of adiposity or food intake. Additionally, adropin could be a regulator of endothelial function.	price>
R-M-153	Insulin B (22-25),CAS: 34367-73-2	Insulin B (22-25),H-Arg-Gly-Phe-Phe-OH is a kind of diabetes peptides.According to data from the International Diabetes Federation,more than 422 million people around the world suffer from diabetes mellitus, a chronic metabolic disorder characterized by hyperglycemia. Diabetes mellitus can be divided into two main types, type 1 or insulin-dependent diabetes mellitus (IDDM) and type 2, or non-insulin-dependent diabetes mellitus (NIDDM). The absolute lack of insulin, due to destruction of the insulin producing pancreaticβ-cells,is the particular disorder in type 1 diabetes.Type 2 diabetes is mainly characterized by the inability of cells to respond to insulin. The condition affects mostly the cells of muscle and fat tissue, and results in a condition known as “insulin resistance”.	price>

...